Liraglutide reverses pronounced insulin-associated weight gain, improves glycaemic control and decreases insulin dose in patients with type 2 diabetes: a 26 week, randomised clinical trial (ELEGANT) - De Wit, H M; Vervoort, G M; Jansen, H J (Diabetologia, 2014)
et al.